SGB confident of booster shot efficacy

Solution Biologics bottling CanSino vaccine at Bukit Jalil. - Filepic

KUALA LUMPUR: Solution Group Bhd (SGB) is confident that the China-based single-dose Convidecia vaccine will be an effective booster shot against the spread of Covid-19 variants.

SGB’s wholly-owned subsidiary, Solution Biologics Sdn Bhd (Solbio), is the Asean manufacturing partner for CanSino’s Convidecia vaccine.

In a statement yesterday, SGB said data from a recent Chinese clinical study showed that a booster shot with the Convidecia vaccine, following a two-dose inactivated vaccine, is effective to produce an immune response to the Covid-19 virus.

“The study by the Jiangsu Centre of Disease Control revealed that the Convidecia booster shot demonstrated an increase of at least 78-fold in average neutralising antibody levels, in comparison with a booster shot with the same inactivated vaccine showing a 15.2-fold increase in antibody levels,” it said.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights

Next In Business News

Budget 2022: MAHB seeks incentives to restore air connectivity
Touch ‘n Go eWallet launches DuitNow transfer
Hong Kong’s IPO market withers as billion-dollar listings lapse
Netflix estimates ‘Squid Game’ will be worth US$900m
Down Is still up for foreign investors piling into China
More opportunities under 12th Malaysia Plan, gig economy to benefit
Second phase of London's Battersea Power Station to be opened to public next year
CPO futures seen trading higher next week on improved sentiment, may hit RM5,050
US to lift restrictions Nov 8 for vaccinated foreign travelers
China aluminium firm Zhongwang flags 'severe difficulties' at subsidiaries

Others Also Read